Form 4: Pacira BioSciences CEO Sells Shares to Cover Tax Obligations

Pacira BioSciences CEO, Frank D. Lee, sold 9,375 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Frank D. Lee, the CEO of Pacira BioSciences, Inc., sold 9,375 shares of common stock on January 2, 2025.
• The sale was executed at a price of $18.33 per share.
• This transaction was to cover tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Mr. Lee directly owns 98,409 shares of Pacira BioSciences common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 9,375 shares is not unusual for a CEO of a company of Pacira's size.
• Similar transactions are regularly reported by executives at comparable companies.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Pacira BioSciences, Frank D. Lee, stock sale, insider trading, tax obligations, restricted stock units, PCRX